Core Objective: Longevity Escape Velocity (LEV) & Strategic Biological Maintenance
| Aspect | Detail |
|---|---|
| Approach | Strategic persistence; rejection of 'natural' decay cycles in favor of active system maintenance. |
| Mindset | Biological Agency: Treating the body as a high-stakes, long-duration engineering project. |
| Area | Protocol |
|---|---|
| Baseline Diagnostics | Comprehensive 'Digital Twin' data: genomics, proteomics, metabolomics, and regular epigenetic clock monitoring. |
| Monitoring | Continuous data streams: CGM (glucose), HRV (heart rate variability), and advanced wearables for metabolic drift detection. |
| Maintenance | Precision metabolic and inflammatory control (e.g., physician-led peptide/metabolic therapy). |
| Detection | High-frequency infrastructure: MCED tests (multi-cancer early detection) and whole-body imaging to identify 'signal' before 'symptom'. |
| Area | Strategy |
|---|---|
| Network Access | Proactive involvement with longevity-focused medical networks/clinics. |
| Literacy | Maintaining high-fidelity research literacy to separate hype from causative clinical data. |
| Strategic Flexibility | Monitoring global regulatory environments for early access to advanced therapies. |
| Priority | Topic |
|---|---|
| 1 | Review clinical data trends regarding senescence therapies and cellular rejuvenation. |
| 2 | Discuss integration of novel diagnostics as they emerge in 2026-2030. |
| 3 | Analyze literature/media for 'case studies' of endurance and long-range agency. |